RDGT saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned negative. In 86 of the 95 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for RDGT turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 32 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
RDGT moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RDGT crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDGT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
RDGT broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +13.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDGT advanced for three days, in 165 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Tickeron Seasonality Score of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 21 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RDGT's P/B Ratio (0.099) is slightly lower than the industry average of (1.374). P/E Ratio (0.002) is within average values for comparable stocks, (-2.158). Projected Growth (PEG Ratio) (1.090) is also within normal values, averaging (0.947). Dividend Yield (0.000) settles around the average of (0.250) among similar stocks. P/S Ratio (0.001) is also within normal values, averaging (2.504).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. RDGT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RDGT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.
YI saw its Momentum Indicator move below the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 77 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for YI turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 32 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
YI moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for YI crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where YI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for YI entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where YI's RSI Oscillator exited the oversold zone, 36 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 74 cases where YI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
Following a +0.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where YI advanced for three days, in 194 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
YI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.224) is normal, around the industry mean (12.613). P/E Ratio (-0.243) is within average values for comparable stocks, (10.633). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.138) among similar stocks. P/S Ratio (0.017) is also within normal values, averaging (4.260).
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. YI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
RDGT | YI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 91 | 79 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 59 Fair valued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 21 | 100 | |
PRICE GROWTH RATING 1..100 | 65 | 82 | |
P/E GROWTH RATING 1..100 | 89 | 20 | |
SEASONALITY SCORE 1..100 | 15 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
YI's Valuation (15) in the Drugstore Chains industry is somewhat better than the same rating for RDGT (59). This means that YI’s stock grew somewhat faster than RDGT’s over the last 12 months.
YI's Profit vs Risk Rating (100) in the Drugstore Chains industry is in the same range as RDGT (100). This means that YI’s stock grew similarly to RDGT’s over the last 12 months.
RDGT's SMR Rating (21) in the Drugstore Chains industry is significantly better than the same rating for YI (100). This means that RDGT’s stock grew significantly faster than YI’s over the last 12 months.
RDGT's Price Growth Rating (65) in the Drugstore Chains industry is in the same range as YI (82). This means that RDGT’s stock grew similarly to YI’s over the last 12 months.
YI's P/E Growth Rating (20) in the Drugstore Chains industry is significantly better than the same rating for RDGT (89). This means that YI’s stock grew significantly faster than RDGT’s over the last 12 months.
| RDGT | YI | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 84% |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 77% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 86% | 2 days ago 82% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 8 days ago 81% | 14 days ago 78% |
| Declines ODDS (%) | 5 days ago 90% | 7 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 84% |
| Aroon ODDS (%) | N/A | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RDGT’s FA Score shows that 1 FA rating(s) are green while YI’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RDGT’s TA Score shows that 2 TA indicator(s) are bullish while YI’s TA Score has 4 bullish TA indicator(s).
RDGT (@Drugstore Chains) experienced а -1.22% price change this week, while YI (@Medical Distributors) price change was -3.16% for the same time period.
The average weekly price growth across all stocks in the @Drugstore Chains industry was +1.32%. For the same industry, the average monthly price growth was +9.75%, and the average quarterly price growth was -47.31%.
The average weekly price growth across all stocks in the @Medical Distributors industry was +3.18%. For the same industry, the average monthly price growth was -9.57%, and the average quarterly price growth was -19.68%.
YI is expected to report earnings on Dec 16, 2026.
The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
@Medical Distributors (+3.18% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
A.I.dvisor tells us that RDGT and YI have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDGT and YI's prices will move in lockstep.
| Ticker / NAME | Correlation To RDGT | 1D Price Change % | ||
|---|---|---|---|---|
| RDGT | 100% | +1.25% | ||
| YI - RDGT | 13% Poorly correlated | +3.19% | ||
| LFMD - RDGT | 12% Poorly correlated | +0.87% | ||
| SCNX - RDGT | 11% Poorly correlated | +0.31% | ||
| HITI - RDGT | 4% Poorly correlated | +0.39% | ||
| PETS - RDGT | 0% Poorly correlated | +0.84% | ||
More | ||||
A.I.dvisor tells us that YI and LFMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YI and LFMD's prices will move in lockstep.